Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells
Authors:
- Lc HofbauerLHLc Hofbauer
- Kc HicokKHKc Hicok
- S KhoslaSKS Khosla
Open Access
- 1 August 2002
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 147 (2) , 269-273
Abstract
BACKGROUND: Estrogens and androgens have anti-resorptive effects on bone, although recent evidence indicates that, even in men, estrogen is the dominant sex steroid regulating bone resorption. The receptor activator of NF-kappaB ligand is essential for osteoclastic bone resorption, and its effects are blocked by the decoy receptor, osteoprotegerin (OPG). While estrogen has been shown to induce osteoblastic OPG production, the effects of androgens on OPG production have not been defined. METHODS: In this study, we assessed the regulation of OPG by androgens in hFOB/AR-6, an immortalized fetal osteoblastic cell line stably transfected with the human androgen receptor (AR), and MSC cells, primary human pluripotent marrow stromal cells capable of differentiating towards mature osteoblasts. RESULTS AND CONCLUSIONS: 5Alpha-dihydrotestosterone (DHT) dose-dependently decreased OPG mRNA levels and protein concentrations in hFOB/AR-6 cells by up to 50 and 60% respectively (P<0.001). Inhibition of OPG mRNA levels and protein production by 5alpha-DHT was completely abrogated by the AR antagonist, hydroxyflutamide (OHF), indicating that these effects are directly mediated by the AR. Of note, OHF alone increased OPG mRNA levels and protein secretion by 2- to 3-fold. Moreover, 5alpha-DHT and testosterone also decreased OPG protein secretion by 40-46% in the untransformed MSC cells, while OHF stimulated it. In conclusion, we demonstrate that androgens specifically inhibit OPG mRNA levels and protein secretion by osteoblastic cells.Keywords
This publication has 17 references indexed in Scilit:
- Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandNature, 1999
- Androgens regulate bone resorption activity of isolated osteoclastsin vitroProceedings of the National Academy of Sciences, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor geneJournal of Cellular Biochemistry, 1997
- Effect of Testosterone and Estradiol in a Man with Aromatase DeficiencyNew England Journal of Medicine, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptorsJournal of Bone and Mineral Research, 1996
- Development and characterization of a conditionally immortalized human fetal osteoblastic cell lineJournal of Bone and Mineral Research, 1995
- Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a ManNew England Journal of Medicine, 1994
- Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.Proceedings of the National Academy of Sciences, 1994